Evidence counts: Latest data from Onyx One-month DAPT program & Renal Denervation – GulfPCR-GIM 2020
Onyx ONE Acute Coronary Syndromes (ACS) Subanalysis - TCT Connect 2020
Onyx ONE Clear Complex PCI Subanalysis - TCT Connect 2020
Onyx ONE Clear Atrial Fibrillation (AF) Subanalysis - TCT Connect 2020
One month DAPT is “becoming standard of care” for high bleeding risk patients following PCI
One month DAPT is the new standard of care for stable patients?_Baber_Coronary On Demand
Short Duration DAPT and DAPT De-Escalation: The New Era of DAPT Post-PCI
STOPDAPT-2 ACT: 1-Month DAPT Followed by Clopidogrel Monotherapy in ACS | Dr Hirotoshi Watanabe
One month dual antiplatelet therapy non inferior to standard regimens- MASTER DAPT TRIAL
Patients with Resistant Hypertension in the Global SYMPLICITY Registry - TCT Connect 2020
Nerve Injury & Regrowth after RDN in Swine Model - Micro Dissection of Human Renal Nervous System
Recent Update on DAPT Strategy for PCI Patients, Prof. Lee, Won Jae
Major study proves Resolute Onyx DES meets primary endpoint in a first-ever clinical study compar...
Antithrombotic strategies after ACS in HBR patients - Prof. Mohammed Sobhy
Short DAPT in high bleeding risk: ready for prime time? - EuroPCR 2021
How should I treat a patient at high-bleeding risk requiring complex distal Left Main PCI for ACS ?
Drugs and devices synergy: optimal DAPT & switching strategies - Round Table Webinar
CardioAssiut - 2020 - Session 3
Controversies in Antiplatelet Therapy for the Secondary Prevention of Cardiovascular Events
DAPT challenges in complex clinical scenarios
08 Mohammed Balghith Stable and Accurate positioning of TAVR using Navitor system with Smart Seal
Mohammed Balghith - SACIS 2015
The problem of INOCA - Webinar
Complete Revascularization: Does One Size Fits All?
Sun Pharma (Dec 2020)